BioSpace

Swiss CDMOs and CROs ride a new wave of growth amid surge in global demand

A surge of consolidation, rising appetite for specialized manufacturing and a shift toward decentralized trials is reshaping Switzerland’s life sciences landscape. From peptide producers to organoid CROs, service providers are scaling and diversifying as global sponsors turn to Swiss hubs for talent, innovation and regulatory strength.

Por BioSpace

1 minuto de lectura
Compartir
Swiss CDMOs and CROs ride a new wave of growth amid surge in global demand
Swiss CDMOs and CROs ride a new wave of growth amid surge in global demand

¿Tiene noticias que compartir con el sector de eventos?

Envíe un comunicado de prensa o una noticia y llegue a miles de profesionales del sector de eventos.

Contáctenos→

Más en Health Tech

Perspectivas relacionadas